Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Rev. méd. Panamá ; 20(1/2): 50-53, Jan.-May 1995.
Artigo em Espanhol | LILACS | ID: lil-409941

RESUMO

The authors reviewed the clinical records of 31 patients with carcinoma of the breast diagnosed at the Dr. Rafael Hernández Hospital in Chiriquí from January 1988 to December 1990. All the patients were women and the average age was 51.9 years. 41.9% of the patients were classified Stage 1; 29%, Stage 2; 16.1%, Stage IIIA; and 12.8%, Stage IIIB. 74% of the patients were treated with a modified radical mastectomy, radiation and hormonal therapies. Systemic cytotoxic therapy was given to 77% of the patients. Total survival 48 months after diagnosis was 83.3% in patients at Stage I; 66%, at Stage II; 40%, at Stage IIIA; and 0%, in patients at Stage IIIB


Assuntos
Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Neoplasias da Mama/patologia , Estadiamento de Neoplasias , Mastectomia , Metástase Linfática , Neoplasias da Mama/mortalidade , Neoplasias da Mama/cirurgia , Panamá/epidemiologia , Terapia Combinada
2.
Rev. méd. Panamá ; 18(3): 217-221, Sept. 1993.
Artigo em Espanhol | LILACS | ID: lil-410000

RESUMO

The authors present the clinical history of a 15-year-old young woman, student, from David, Chiriquí, who complained of menstrual irregularities associated with the sensation of a mass in the right iliac fossa. Exploratory laparotomy revealed a right ovarian tumor, which was totally resected. The histopathological examination showed an endodermal sinus tumor, stage one, in the right ovary. The patient received four cycles of cytotoxic i.v. therapy every 3 weeks, after surgery, with vinblastine 6 mg/m2 body surface (B.S.) on days 1 and 2, bleomycin 15 u daily for 5 days, cisplatin 20 mg/m2 B.S. daily for 5 days, plus hydration with normal saline (5 to 6 l/day). Follow up studies with abdominal and pelvic sonograms, chest x-ray, feto protein and physical examination have not shown evidence of tumor activity 36 months after diagnosis


Assuntos
Humanos , Feminino , Adolescente , Neoplasias Ovarianas/patologia , Tumor do Seio Endodérmico/patologia , Neoplasias Ovarianas/terapia , Ovário/patologia , Terapia Combinada , Tumor do Seio Endodérmico/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA